98 related articles for article (PubMed ID: 30783036)
41. MAP3K7 is recurrently deleted in pediatric T-lymphoblastic leukemia and affects cell proliferation independently of NF-κB.
Cordas Dos Santos DM; Eilers J; Sosa Vizcaino A; Orlova E; Zimmermann M; Stanulla M; Schrappe M; Börner K; Grimm D; Muckenthaler MU; Kulozik AE; Kunz JB
BMC Cancer; 2018 Jun; 18(1):663. PubMed ID: 29914415
[TBL] [Abstract][Full Text] [Related]
42. An X-linked tumor suppressor in T-ALL.
Ariës IM; Gutierrez A
Blood; 2015 Jan; 125(1):3-4. PubMed ID: 25554741
[No Abstract] [Full Text] [Related]
43. Precursor T-cell acute lymphoblastic leukemia/lymphoma involving the uterine cervix, myometrium, endometrium, and appendix.
Lyman MD; Neuhauser TS
Ann Diagn Pathol; 2002 Apr; 6(2):125-8. PubMed ID: 12004362
[TBL] [Abstract][Full Text] [Related]
44. Notch in Leukemia.
McCarter AC; Wang Q; Chiang M
Adv Exp Med Biol; 2018; 1066():355-394. PubMed ID: 30030836
[TBL] [Abstract][Full Text] [Related]
45. Rictor/mammalian target of rapamycin 2 regulates the development of Notch1 induced murine T-cell acute lymphoblastic leukemia via forkhead box O3.
Hua C; Guo H; Bu J; Zhou M; Cheng H; He F; Wang J; Wang X; Zhang Y; Wang Q; Zhou J; Cheng T; Xu M; Yuan W
Exp Hematol; 2014 Dec; 42(12):1031-40.e1-4. PubMed ID: 25201756
[TBL] [Abstract][Full Text] [Related]
46. Differential WNT gene expression in various subtypes of acute lymphoblastic leukemia.
Memarian A; Vosough P; Asgarian-Omran H; Tabrizi M; Shabani M; Shokri F
Iran J Immunol; 2012 Mar; 9(1):61-71. PubMed ID: 22426169
[TBL] [Abstract][Full Text] [Related]
47. Resorptive hypercalcemia in post-essential thrombocythemia myelofibrosis: treatment with denosumab.
Khoury N; Chang J; Gru AA; Whyte MP
J Clin Endocrinol Metab; 2012 Sep; 97(9):3051-5. PubMed ID: 22730513
[TBL] [Abstract][Full Text] [Related]
48. T-lymphoblastic leukaemia/lymphoma with rosettes and gland-like structures.
Yang Y; Juskevicius R
Br J Haematol; 2020 Oct; 191(2):141. PubMed ID: 32634863
[No Abstract] [Full Text] [Related]
49. The relevance of PTEN-AKT in relation to NOTCH1-directed treatment strategies in T-cell acute lymphoblastic leukemia.
Mendes RD; Canté-Barrett K; Pieters R; Meijerink JP
Haematologica; 2016 Sep; 101(9):1010-7. PubMed ID: 27582570
[TBL] [Abstract][Full Text] [Related]
50. Increased RANKL and IL-6 levels might result in high bone turnover in a case of a CD34+/CD117+/myeloperoxidase(+dim) acute myeloid leukemia presenting with severe hypercalcemia and lumbar spine fractures.
Giannakoulas NC; Terpos E; Palassopoulou M; Zolota V; Lampropoulou P; Symeonidis A; Matsouka P
Leuk Res; 2011 Nov; 35(11):e188-9. PubMed ID: 21802729
[No Abstract] [Full Text] [Related]
51. CXCR4 Is Required for Leukemia-Initiating Cell Activity in T Cell Acute Lymphoblastic Leukemia.
Passaro D; Irigoyen M; Catherinet C; Gachet S; Da Costa De Jesus C; Lasgi C; Tran Quang C; Ghysdael J
Cancer Cell; 2015 Jun; 27(6):769-79. PubMed ID: 26058076
[TBL] [Abstract][Full Text] [Related]
52. In vitro susceptibility to TRAIL-induced apoptosis of acute leukemia cells in the context of TRAIL receptor gene expression and constitutive NF-kappa B activity.
Wuchter C; Krappmann D; Cai Z; Ruppert V; Scheidereit C; Dörken B; Ludwig WD; Karawajew L
Leukemia; 2001 Jun; 15(6):921-8. PubMed ID: 11417478
[TBL] [Abstract][Full Text] [Related]
53. Gene expression profiling: a possible tool in the prediction of outcome in paediatric acute lymphoblastic leukaemia?
Lanciotti M; D'Apolito M; Paolucci P; Indaco S; Dufour C
Br J Haematol; 2011 Apr; 153(2):279-82. PubMed ID: 21275956
[No Abstract] [Full Text] [Related]
54. Late recurrence of childhood T-cell acute lymphoblastic leukemia frequently represents a second leukemia rather than a relapse: first evidence for genetic predisposition.
Szczepanski T; van der Velden VH; Waanders E; Kuiper RP; Van Vlierberghe P; Gruhn B; Eckert C; Panzer-Grümayer R; Basso G; Cavé H; Stadt UZ; Campana D; Schrauder A; Sutton R; van Wering E; Meijerink JP; van Dongen JJ
J Clin Oncol; 2011 Apr; 29(12):1643-9. PubMed ID: 21357790
[TBL] [Abstract][Full Text] [Related]
55. Ezh2 Controls an Early Hematopoietic Program and Growth and Survival Signaling in Early T Cell Precursor Acute Lymphoblastic Leukemia.
Danis E; Yamauchi T; Echanique K; Zhang X; Haladyna JN; Riedel SS; Zhu N; Xie H; Orkin SH; Armstrong SA; Bernt KM; Neff T
Cell Rep; 2016 Mar; 14(8):1953-65. PubMed ID: 26904942
[TBL] [Abstract][Full Text] [Related]
56. NF-kappaB involvement in the activation of primary adult T-cell leukemia cells and its clinical implications.
Arima N; Matsushita K; Obata H; Ohtsubo H; Fujiwara H; Arimura K; Kukita T; Suruga Y; Wakamatsu S; Hidaka S; Tei C
Exp Hematol; 1999 Jul; 27(7):1168-75. PubMed ID: 10390192
[TBL] [Abstract][Full Text] [Related]
57. Production of parathyroid hormone-related peptide in a patient with acute lymphocytic leukemia with extensive osteolytic lesions and hypercalcemia.
Miyamura T; Taguchi F; Ishikura H; Yufu Y; Nishi Y; Yamashita S; Nishimura J; Nawata H
Am J Hematol; 1995 Oct; 50(2):150-1. PubMed ID: 7573001
[No Abstract] [Full Text] [Related]
58. Highly aggressive lymphomas in adults.
Sweetenham JW
Hematol Oncol Clin North Am; 2008 Oct; 22(5):965-78, ix. PubMed ID: 18954746
[TBL] [Abstract][Full Text] [Related]
59. IL-4 inhibits bone-resorbing activity of mature osteoclasts by affecting NF-kappa B and Ca2+ signaling.
Mangashetti LS; Khapli SM; Wani MR
J Immunol; 2005 Jul; 175(2):917-25. PubMed ID: 16002690
[TBL] [Abstract][Full Text] [Related]
60. [Demonstration of leukemic stem cells in the human T-ALLs and study of the involvement of the NOTCH, TAL1 and ERK/MAPK pathways in human T-leukemogenesis].
Gerby B; Armstrong F; Brunet de la Grange P; Calvo J; Ballerini P; Pflumio F
Ann Pathol; 2008 Nov; 28 Spec No 1(1):S28-9. PubMed ID: 18984291
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
